Table 3 Antibiotic resistance pattern of predominant Gram-negative blood stream isolates in Covid-19 ICU patients (%)
From: Clinical profile of bloodstream infections in COVID-19 patients: a retrospective cohort study
Antibiotic | Acinetobacter baumannii (n = 21) | Klebsiella pneumoniae (n = 14) | Psuedomonas aeruginosa (n = 4) | Escherichia coli (n = 7) | Burkholderia cepacia complex (n = 4) | Elizabethkingia spp. (n = 3) |
|---|---|---|---|---|---|---|
Ceftriaxone | 76.2 | 71.4 | NA | 100 | NA | NA |
Cefepime | 52.4 | 78.6 | 0 | 85.7 | NA | 66.6 |
Ceftazidime | NA | NA | NA | NA | 50 | NA |
Piperacillin-Tazobactam | 76.2 | 78.6 | 0 | 71.4 | NA | 33.3 |
Meropenem | 33.3 | 21.4 | 0 | 14.3 | 75 | 100 |
Colistin | 9.5 | 7.1 | 0 | 14.3 | 50 | 33.3 |
Ciprofloxacin/Levofloxacin | 66.7 | 78.6 | NA | 85.7 | 50 | NA |
Cefoperazone/sulbactam | NA | 71.4 | 0 | 57.1 | NA | NA |
Amikacin | 52.4 | 57.1 | 0 | 57.1 | NA | 66.6 |
Tigecycline | 0 | 0 | NA | 0 | NA | NA |
Aztreonam | NA | 85.7 | 50 | 71.4 | NA | 66.6 |
Imipenem | 9.5 | NA | 0 | 28.6 | NA | NA |
Ertapenem | 23.8 | 71.4 | NA | NA | NA | NA |